Alkali Metals Ltd (BSE: 533029) is a Hyderabad, Telangana-based company in the Industrial Inorganic Chemicals industry. With a market capitalisation of ₹81 Cr, it ranks #3,406 by market cap among the 6,197 Indian listed companies on FinBizNet, and #35 of 39 in Industrial Inorganic Chemicals. At ₹78.50 (as of 16 Nov 2026), the share price is 26.2% below its 52-week high of ₹106.30 and 67.7% above its 52-week low of ₹46.80. The share price is down 14.4% over one year and up 12.6% over three months.
| Current Price | ₹78.50 |
|---|---|
| Market Cap | ₹81 Cr |
| BSE Code | 533029 |
| Sector | Materials > Chemicals > Commodity Chemicals |
| Sub-Industry | Commodity Chemicals > Industrial Inorganic Chemicals |
| P/E Ratio | 148.5 |
| Return on Equity | 1.26% |
| Return on Assets | 3.21% |
| 52-Week Range | ₹46.80 – ₹106.30 |
| 1-Year Price Change | -14.4% |
| 3-Month Price Change | +12.6% |
| Beta (1Y) | 0.83 |
| Dividend Yield | 1.23% |
| Headquarters | Hyderabad, Telangana |
| Website | www.alkalimetals.com |
| Revenue | ₹27 Cr |
|---|---|
| Net Profit | ₹1 Cr |
| Net Margin | 2.1% |
| EPS (Basic) | ₹0.56 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Alkali Metals Ltd reported revenue of ₹27 Cr in Q2 FY27, up 45.3% from ₹19 Cr in Q2 FY26 and up 55.2% from ₹18 Cr in Q1 FY27. It posted a net profit of ₹1 Cr for the quarter, against a net loss of ₹1 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹18 Cr (Q1 FY27) to ₹29 Cr (Q4 FY26). The company reported a net loss in 4 of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹27 Cr | ₹1 Cr | 2.1% |
| Q1 FY27 | ₹18 Cr | −₹1 Cr | −3.6% |
| Q4 FY26 | ₹29 Cr | ₹4 Cr | 14.0% |
| Q3 FY26 | ₹25 Cr | −₹1 Cr | −5.6% |
| Q2 FY26 | ₹19 Cr | −₹1 Cr | −4.8% |
| Q1 FY26 | ₹21 Cr | −₹1 Cr | −5.6% |
| Q4 FY25 | ₹25 Cr | ₹4 Cr | 17.5% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 69.59% of Alkali Metals Ltd's shares as of Jun 2026, unchanged from Sept 2025. Delivery averaged 100.0% of traded volume across 13 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, quinoline, tetrazole, and triazole compounds; azaindole, potassium, sodium, and other metal derivatives; boronic acids, and DSSC and OLED materials; and organic, inorganic, and fine chemicals. The company’s products are used in pharma intermediates, anti retrovirals, flu vaccines, antibiotics, cardio/anti inflammation, agrochemicals, and automobiles applications. Alkali Metals Limited was incorporated in 1968 and is based in Hydera
1. Manufacture and Sale of Chemicals-This segment manufactures and sells sodium derivatives, pyridine derivatives, and fine chemicals. It also offers APIs/intermediates for the pharmaceutical sector. 2. Manufactured Goods-Thsi segment manufactures and sells sodium derivatives, pyridine derivatives, and a range of fine chemicals based on related chemistry in India. 3. Unit - I (Uppal)-This segment engages in trading of coal. 4. Unit - II (Dommara Pochampally)-This segment manufactures and sells sodium derivatives, such as sodium amide, sodium azide, sodium hydride, sodium methoxide, and sodium tertiary butoxide; pyridine derivatives comprising 2 aminopyridine, 2-amino-4-methylpyridine, 2-amino-6-methylpyridine, 2,6 diaminopyridine, and 2,3,5 trichloropyridine; and fine chemicals that consis
1. Manufacture and Sale of Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Deepak Nitrite Ltd | ₹22,169 Cr | 40.3 | 9.75% | ₹3,076 Cr | -7.3% |
| Tata Chemicals Ltd | ₹15,409 Cr | n/m | -7.68% | ₹4,177 Cr | -29.4% |
| Tanfac Industries Ltd. | ₹7,305 Cr | 96.2 | 20.48% | ₹187 Cr | +66.1% |
| Gujarat Alkalies And Chemicals L | ₹4,453 Cr | n/m | -0.04% | ₹1,358 Cr | +5.8% |
| GHCL Ltd | ₹4,007 Cr | 8.9 | 13.42% | ₹808 Cr | -28.0% |
| Vishnu Chemicals Ltd. | ₹3,749 Cr | 26.2 | 14.22% | ₹430 Cr | +11.1% |
| Bodal Chemicals Ltd. | ₹2,048 Cr | 43 | 4.23% | ₹863 Cr | +165.8% |
| DCW Ltd | ₹1,649 Cr | 29 | 4.57% | ₹663 Cr | -28.7% |
| Alkali Metals Ltd | ₹81 Cr | 148.5 | 1.26% | ₹27 Cr | -14.4% |
Listed by market capitalisation. Ratios are shown for context only.
Alkali Metals Ltd is trading at ₹78.50, with a market capitalisation of ₹81 Cr.
Alkali Metals Ltd operates in the Materials > Chemicals > Commodity Chemicals space (Commodity Chemicals > Industrial Inorganic Chemicals).
Alkali Metals Ltd has a P/E of 148.5 and a return on equity of 1.26%.
Alkali Metals Ltd is listed on the BSE under the scrip code 533029.
Alkali Metals Ltd's share price is down 14.4% over one year and up 12.6% over three months. Its 52-week range is ₹46.80 to ₹106.30.
In Q2 FY27, Alkali Metals Ltd reported revenue of ₹27 Cr and net profit of ₹1 Cr, with basic EPS of ₹0.56 (standalone, parsed from the company's exchange filing).
Alkali Metals Ltd reported revenue of ₹27 Cr in Q2 FY27, up 45.3% from ₹19 Cr in Q2 FY26 and up 55.2% from ₹18 Cr in Q1 FY27.
Promoters held 69.59% of Alkali Metals Ltd's shares as of Jun 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.